Chidamide and cytarabine synergistically treat acute myeloid leukemia: inhibiting ribosome biogenesis via the MYC-RRP9 pathway

Abstract This study explores innovative therapeutic approaches for acute myeloid leukemia by examining the synergistic effects of the histone deacetylase inhibitor chidamide in combination with cytarabine. In both in vitro and in vivo models, the drug combination demonstrated significant synergism i...

詳細記述

書誌詳細

主要な著者:	Qing Li, Fangfang Wang, Xinrong Xiang, Lei Zhao, Xuefeng Li, Ying Qu, Jingcao Huang, Yunfan Yang, Yang Dai, Xiao Shuai, Jiazhuo Liu, Jie Huang, Yu Liu, Yu Wu
フォーマット:	Artigo
言語:	Inglês
出版事項:	Nature Publishing Group 2025-08-01
シリーズ:	Cell Death and Disease
オンライン･アクセス:	https://doi.org/10.1038/s41419-025-07928-y
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!